Tate & Lyle completes maltodextrin capacity expansion

Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, is pleased to announce the completion of the doubling of capacity of its non-GMO MALTOSWEET® Maltodextrin production line at its facility in Boleraz, Slovakia.

This major expansion enables Tate & Lyle to meet growing global demand for food grade and infant food grade MALTOSWEET® Maltodextrin.  Nick Hampton, Chief Executive of Tate & Lyle, joined employees and local dignitaries from Boleraz for a ceremony to celebrate the formal opening of the expanded capacity.

MALTOSWEET® Maltodextrin is a nutritive corn-based speciality sweetener made from locally sourced non-GMO corn. It is available in powder and granular formats. Maltodextrin acts as a binder, viscosity provider, fat replacer and bulking agent. The ingredient is used in a wide range of food and beverages such as infant formula, sports drinks, dairy desserts and sauces.

Murat Orhon, SVP and General Manager, Europe, Middle East and Africa, Food & Beverage Solutions for Tate & Lyle, said:

“We have invested in our facility in Boleraz to ensure our customers, particularly producers of infant and growing-up formula who are key users of maltodextrin, can continue to offer products that meet high quality standards, in line with growing global demand.

“The market for these products that nourish children and support families is particularly strong in Europe, but is also growing in markets such as the Middle East, Africa and Asia Pacific.”

About Tate & Lyle: 
Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants).  It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2019, Tate & Lyle sales totalled £2.8 billion. For more information, please visit http://www.tateandlyle.com